HomeAPUS • NYSEAMERICAN
add
Apimeds Pharmaceuticals US Inc
Previous close
$2.26
Day range
$2.06 - $2.26
Year range
$1.37 - $4.03
Market cap
26.91M USD
Avg Volume
131.96K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.84M | 514.75% |
Net income | -1.78M | -435.68% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.84M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.99M | 26,194.14% |
Total assets | 9.25M | 24,963.09% |
Total liabilities | 1.09M | 0.55% |
Total equity | 8.16M | — |
Shares outstanding | 12.58M | — |
Price to book | 3.48 | — |
Return on assets | -46.58% | — |
Return on capital | -48.79% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.78M | -435.68% |
Cash from operations | -1.73M | -824.29% |
Cash from investing | -22.54K | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -1.75M | -4,657.74% |
Free cash flow | -1.38M | -1,532.99% |
About
Founded
2020
Headquarters
Website
Employees
2
